Cite
HARVARD Citation
Buijs, S. et al. (n.d.). The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer. European journal of cancer. pp. S58-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Buijs, S. et al. (n.d.). The impact of therapeutic drug monitoring-based tamoxifen dose-reductions on endocrine side effects in patients with primary breast cancer. European journal of cancer. pp. S58-. [Online].